ATE104150T1 - Haemoglobinzusammensetzung und ihre verwendung. - Google Patents

Haemoglobinzusammensetzung und ihre verwendung.

Info

Publication number
ATE104150T1
ATE104150T1 AT90908306T AT90908306T ATE104150T1 AT E104150 T1 ATE104150 T1 AT E104150T1 AT 90908306 T AT90908306 T AT 90908306T AT 90908306 T AT90908306 T AT 90908306T AT E104150 T1 ATE104150 T1 AT E104150T1
Authority
AT
Austria
Prior art keywords
desirable
composition
hemoglobin
chains
beta
Prior art date
Application number
AT90908306T
Other languages
English (en)
Inventor
Wilhelmus Antonius Mar Berbers
Petrus Theodorus Mari Biessels
Willem Karel Bleeker
Joachim Cornelis Bakker
Original Assignee
Nederlanden Staat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nederlanden Staat filed Critical Nederlanden Staat
Application granted granted Critical
Publication of ATE104150T1 publication Critical patent/ATE104150T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Containers And Plastic Fillers For Packaging (AREA)
  • Peptides Or Proteins (AREA)
AT90908306T 1989-05-10 1990-05-09 Haemoglobinzusammensetzung und ihre verwendung. ATE104150T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8901174A NL8901174A (nl) 1989-05-10 1989-05-10 Hemoglobine-preparaat en gebruik daarvan.
PCT/NL1990/000067 WO1990013309A1 (en) 1989-05-10 1990-05-09 A hemoglobin composition and its use

Publications (1)

Publication Number Publication Date
ATE104150T1 true ATE104150T1 (de) 1994-04-15

Family

ID=19854627

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90908306T ATE104150T1 (de) 1989-05-10 1990-05-09 Haemoglobinzusammensetzung und ihre verwendung.

Country Status (8)

Country Link
EP (1) EP0475971B1 (de)
AT (1) ATE104150T1 (de)
CA (1) CA2060205A1 (de)
DE (1) DE69008173T2 (de)
DK (1) DK0475971T3 (de)
ES (1) ES2055432T3 (de)
NL (1) NL8901174A (de)
WO (1) WO1990013309A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5449759A (en) * 1987-05-16 1995-09-12 Somatogen, Inc. Hemoglobins with intersubunit desulfide bonds
US5545727A (en) * 1989-05-10 1996-08-13 Somatogen, Inc. DNA encoding fused di-alpha globins and production of pseudotetrameric hemoglobin
CA2122717C (en) * 1991-11-08 2003-07-15 David C. Anderson Hemoglobins as drug delivery agents
US5334706A (en) * 1992-01-30 1994-08-02 Baxter International Administration of low dose hemoglobin to increase perfusion
US5900477A (en) * 1992-01-30 1999-05-04 Baxter International, Inc. Use of hemoglobin in the treatment of hemorrhagic shock
IS4198A (is) * 1993-08-13 1995-02-14 Somatogen, Inc Meðferð vegna aukaverkana sem tengjast gjöf á utanfrumublóðrauða
DE4418973A1 (de) * 1994-05-31 1995-12-14 Barnikol Wolfgang Verfahren zur Herstellung molekular-einheitlicher hyperpolymerer Hämoglobine
CA2180529A1 (en) * 1994-11-17 1996-05-30 John Blue Hemoglobin therapy in hemodialysis
JP4583510B2 (ja) 1997-02-28 2010-11-17 ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア 無細胞系による酸素輸送の最適化のための方法と組成物
US5814601A (en) * 1997-02-28 1998-09-29 The Regents Of The University Of California Methods and compositions for optimization of oxygen transport by cell-free systems
US20050164915A1 (en) 2002-04-01 2005-07-28 Sangart, Inc. Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
US20140227677A1 (en) * 2013-02-07 2014-08-14 OPK Biotech, LLC Perfusion of prospective donor hearts with polymerized hemoglobin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826811A (en) * 1986-06-20 1989-05-02 Northfield Laboratories, Inc. Acellular red blood cell substitute
IL87707A (en) * 1988-09-08 1994-06-24 Technion Inst For Research And Hemoglobin-based blood substitute substantially similar to human blood and method for preparation thereof
IL87708A (en) * 1988-09-08 1994-04-12 Technion Inst For Research And Hemoglobin-based blood substitute possessing a colloid oncotic pressure substantially similar to human blood and method for the preparation thereof

Also Published As

Publication number Publication date
ES2055432T3 (es) 1994-08-16
EP0475971A1 (de) 1992-03-25
NL8901174A (nl) 1990-12-03
WO1990013309A1 (en) 1990-11-15
DE69008173T2 (de) 1994-07-28
CA2060205A1 (en) 1990-11-11
DE69008173D1 (de) 1994-05-19
DK0475971T3 (da) 1994-07-11
EP0475971B1 (de) 1994-04-13

Similar Documents

Publication Publication Date Title
ATE104150T1 (de) Haemoglobinzusammensetzung und ihre verwendung.
DK151687A (da) Aprotinin-homologe fremstillet ud fra en rekombinant vaert, fremgangsmaade, ekspressionsvektor og rekombinant vaert derfor og farmaceutisk anvendelse deraf
FI946004A0 (fi) Lääketieteellisessä toimenpiteessä käytettävä trombiiniverifraktio
EA200000994A1 (ru) Применение кабэрголина при лечении синдрома усталых ног
ATE115160T1 (de) Biologisch abbaubare polyphosphoester.
DE69420975D1 (de) Amido-siladiylverbrückte katalysatorkomponente, verfahren zur herstellung und verwendung
NO951740L (no) Preparater av eikebarkekstrakt, beslektede syntetiske preparater og fremgangsmåte for anvendelse av disse
NO904291D0 (no) Fremgangsmaate for fremstilling av radiomerkede antikoagulerende peptider.
ES2113957T3 (es) Preparacion farmaceutica conteniendo un agente uricosurico y un antagonista de aminoacidos excitadores.
EP0372670A3 (de) Hirudinverwandte Peptide zur Verhinderung der Plättchenaggregation
AU7470687A (en) Compositions for preventing graft rejection
ATE263187T1 (de) Neuartige heparin bindende peptide
UA41332C2 (uk) Білок, здатний інгібувати стимульовану колагеном агрегацію тромбоцитів, спосіб його одержання, фармацевтичний препарат, спосіб обробки імплантованого або екстракорпорального медичного пристрою та спосіб одержання лікарського засобу
BR0015757A (pt) Composição orgânica polimerizável, artigo polimerizado e artigo fotocrÈmico
PT684816E (pt) Composicoes antagonistas do receptor da 5-ht2 uteis no tratamento de doencas venosas
HUP0002836A2 (hu) Makrociklusos bisz(3,3'-indolil)-maleinimid-származékok alkalmazása bőrrendellenességek kezelésére szolgáló gyógyszerkészítmények előállítására
NZ235497A (en) Peptides (possibly related to hirudin) and pharmaceutical compositions for reducing blood coagulation
DK226889D0 (da) Alkoholpeptidderivat samt anvendelse deraf til mindskning af blodkoagulation
EP0058397A3 (de) Antikoagulans und seine Verwendung
NO894880D0 (no) Fremgangsmaate for fremstilling av antikoagulerende peptider.
MY109804A (en) Absorbable dusting powder derived from starch.
NO921317L (no) Antimetastatisk virkende midler
DE69119900D1 (de) Verwendung von Prostaglandin F3alpha als okulares Hypotensivum
DK563886A (da) Terapeutisk komposition

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee